Ashkon Software

   







 


CAPN - Capnia, Inc.

Capnia, Inc. logo Capnia, Inc. is a biotechnology company that develops and commercializes innovative diagnostic and therapeutic products for respiratory and critical care markets. The company's technology platform is based on its proprietary carbon dioxide (CO2) management technology, which enables the use of CO2 as a medical tool for diagnostic and therapeutic purposes.

Capnia's lead product candidate is the CoSense system, a non-invasive device that measures the exhaled CO2 levels in a patient's breath to monitor the effectiveness of treatment for carbon monoxide poisoning. The CoSense system has been approved by the FDA and is currently being marketed in the United States.

The company is also developing the Serenz system, a handheld device that delivers a non-invasive, low-dose CO2 stream to the nasal passages to treat the symptoms of allergic rhinitis, a common condition that causes inflammation of the nasal passages. The Serenz system is currently in clinical trials and has not yet been approved by the FDA.

Capnia was founded in 2005 and is headquartered in Redwood City, California. The company is publicly traded on the NASDAQ exchange under the ticker symbol "

 



 

 

 
Copyright © 2000-2024, Ashkon Software LLC
Privacy Policy | Refund Policy | Disclaimer